Evidence map›Paper›PMID 31346033›Full record

ArticleThe Journal of biological chemistry2019

Structure-based optimization of a PDZ-binding motif within a viral peptide stimulates neurite outgrowth.

Zakir Khan, Elouan Terrien, Florent Delhommel, Cynthia Lefebvre-Omar, Delphine Bohl, Sandrine Vitry, Clara Bernard, Juan Ramirez, Alain Chaffotte, Kevin Ricquier and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. DexDesign: an OSPREY-based algorithm for designing de novo D-peptide inhibitors.Protein engineering, design & selection : PEDS · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. The Role ofFrontiers in molecular neuroscience · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Zakir KhanInstitut Pasteur, Unité de Neuroimmunologie Virale, UMR 3569, CNRS, Paris 75015, France.
Elouan TerrienInstitut Pasteur, Unité de RMN des Biomolécules, UMR 3528, CNRS, Paris 75015, France.
Florent DelhommelInstitut Pasteur, Unité de RMN des Biomolécules, UMR 3528, CNRS, Paris 75015, France.
Cynthia Lefebvre-OmarInstitut du Cerveau et de la Moelle Epinière, ICM, U1127 INSERM, UMR 7225 CNRS, Sorbonne Université, Paris 75013, France.
Delphine BohlInstitut du Cerveau et de la Moelle Epinière, ICM, U1127 INSERM, UMR 7225 CNRS, Sorbonne Université, Paris 75013, France.
Sandrine VitryInstitut Pasteur, Unité de Neuroimmunologie Virale, UMR 3569, CNRS, Paris 75015, France.ORCID 0000-0003-4693-7694
Clara BernardInstitut Pasteur, Unité de Neuroimmunologie Virale, UMR 3569, CNRS, Paris 75015, France.
Juan RamirezInstitut Pasteur, Unité de RMN des Biomolécules, UMR 3528, CNRS, Paris 75015, France.
Alain ChaffotteInstitut Pasteur, Unité de RMN des Biomolécules, UMR 3528, CNRS, Paris 75015, France.
Kevin RicquierInstitut Pasteur, Unité de RMN des Biomolécules, UMR 3528, CNRS, Paris 75015, France.
Renaud VincentelliUnité Mixte de Recherche 7257, CNRS Aix-Marseille Université, Architecture et Fonction des Macromolécules Biologiques (AFMB), Marseille 13009, France.
Henri BucInstitut Pasteur, Paris 75015, France.
Christophe PrehaudInstitut Pasteur, Unité de Neuroimmunologie Virale, UMR 3569, CNRS, Paris 75015, France.
Nicolas WolffInstitut Pasteur, Unité de RMN des Biomolécules, UMR 3528, CNRS, Paris 75015, France.ORCID 0000-0002-4950-706X
Monique LafonInstitut Pasteur, Unité de Neuroimmunologie Virale, UMR 3569, CNRS, Paris 75015, France monique.lafon@pasteur.fr.ORCID 0000-0002-4423-7996
Centre National de la Recherche Scientifique · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protection of neuronal homeostasis is a major goal in the management of neurodegenerative diseases. Microtubule-associated Ser/Thr kinase 2 (MAST2) inhibits neurite outgrowth, and its inhibition therefore represents a potential therapeutic strategy. We previously reported that a viral protein (G-protein from rabies virus) capable of interfering with protein-protein interactions between the PDZ domain of MAST2 and the C-terminal moieties of its cellular partners counteracts MAST2-mediated suppression of neurite outgrowth. Here, we designed peptides derived from the native viral protein to increase the affinity of these peptides for the MAST2-PDZ domain. Our strategy involved modifying the length and flexibility of the noninteracting sequence linking the two subsites anchoring the peptide to the PDZ domain. Three peptides, Neurovita1 (NV1), NV2, and NV3, were selected, and we found that they all had increased affinities for the MAST2-PDZ domain, with

Indexed as

Central Nervous System StimulantsHumansInduced Pluripotent Stem CellsMicrotubulesNeuritesNeuronal OutgrowthNeuronsPDZ DomainsPeptidesProtein Interaction Domains and MotifsProtein Serine-Threonine KinasesRabies virusStructure-Activity RelationshipViral ProteinsCentral Nervous System StimulantsPeptidesProtein Serine-Threonine KinasesViral Proteinsinterfering peptideneurite outgrowthneurodegenerative diseasesnuclear magnetic resonancePDZ domainprotein–protein interactionserine/threonine protein kinasestructure–function analysistherapeutic drug candidateviral protein

Identifiers

PMID31346033
PMCPMC6746437
OpenAlexW2963255928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.